Earnings · US stocks

Praxis Precision Medicines, Inc. (PRAX) earnings

Praxis Precision Medicines, Inc. published its quarterly report on 2026-11-09. The stock moved +24.71% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-09
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+19.94%—
3 days+24.71%—
7 days+9.88%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 5 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +4.18%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-09-3.23+11.13%+24.71%——
2026-08-06-2.87+22.22%+14.95%-2.74%-1.81%
2026-05-07-3.20+13.01%-1.85%-16.49%-18.25%
2026-02-19-3.50-11.99%+4.11%-2.93%+1.59%
2025-11-05-3.36+3.72%-2.06%+54.79%+55.36%
2025-08-04-3.31+1.43%-10.15%-25.22%-31.52%
2025-05-02-3.29-2.46%-7.59%+16.40%+9.50%
2025-02-28-2.94-4.29%+11.36%-12.44%-2.10%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: PRAX

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.